Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Biomerica (BMRA) over the last 15 years, with Q4 2025 value amounting to $72000.0.

  • Biomerica's Share-based Compensation fell 5354.84% to $72000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $404000.0, marking a year-over-year decrease of 4793.81%. This contributed to the annual value of $460000.0 for FY2025, which is 4504.18% down from last year.
  • As of Q4 2025, Biomerica's Share-based Compensation stood at $72000.0, which was down 5354.84% from $133000.0 recorded in Q3 2025.
  • In the past 5 years, Biomerica's Share-based Compensation ranged from a high of $522180.0 in Q1 2021 and a low of $72000.0 during Q4 2025
  • Its 5-year average for Share-based Compensation is $238573.4, with a median of $252316.0 in 2022.
  • Its Share-based Compensation has fluctuated over the past 5 years, first surged by 23062.13% in 2021, then crashed by 7323.53% in 2025.
  • Quarter analysis of 5 years shows Biomerica's Share-based Compensation stood at $314397.0 in 2021, then grew by 1.15% to $318000.0 in 2022, then plummeted by 61.64% to $122000.0 in 2023, then rose by 27.05% to $155000.0 in 2024, then tumbled by 53.55% to $72000.0 in 2025.
  • Its Share-based Compensation stands at $72000.0 for Q4 2025, versus $133000.0 for Q3 2025 and $108000.0 for Q2 2025.